Clinical Trials Logo

Clinical Trial Details — Status: Approved for marketing

Administrative data

NCT number NCT02471781
Other study ID # 10-001 CA
Secondary ID
Status Approved for marketing
Phase
First received
Last updated

Study information

Verified date January 2020
Source Cook Group Incorporated
Contact n/a
Is FDA regulated No
Health authority
Study type Expanded Access

Clinical Trial Summary

The Zenith TX2 Low Profile TAA Endovascular Graft extended study is to collect confirmatory safety and effectiveness data. The Zenith TX2 Low Profile TAA Endovascular Graft is indicated for the treatment of patients with a descending thoracic aortic aneurysm or penetrating ulcer and has an anatomy suitable for repair.


Other known NCT identifiers
  • NCT02319551

Recruitment information / eligibility

Status Approved for marketing
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Meets one of the following

- Descending thoracic aneurysm with diameter = 5.0 cm

- Descending thoracic aneurysm with a history of growth = 0.5 cm per year

- Descending thoracic degenerative or atherosclerotic ulcer = 10 mm in depth and 20 mm in diameter

Exclusion Criteria:

- Life expectancy less than 2 years

- Pregnant of breastfeeding or planning on becoming pregnant within 60 months

- Unwilling to comply with the follow-up schedule

- Less than 30 days beyond primary endpoint for other investigative drug or device study

- Receiving home oxygen

- Myocardial infarction within the last 3 months

- Stroke within the last 3 months

- Diagnosed or suspected congenital degenerative collagen disease

- Systemic infection

- Bleeding diathesis, uncorrectable coagulopathy, or refuses blood transfusion

- Allergy to polyester, polypropylene, nitinol, or gold

- Previous placement of a thoracic endovascular graft

- Prior open repair involving the descending thoracic aorta

Study Design


Intervention

Device:
Zenith TX2 Low Profile TAA Endovascular Graft
Endovascular treatment of patients with aneurysms or ulcers of the descending thoracic aorta having morphology suitable for endovascular repair.

Locations

Country Name City State
United States University of Michigan Health System Ann Arbor Michigan
United States Emory University Atlanta Georgia
United States Cooper University Hospital Camden New Jersey
United States University of North Carolina Chapel Hill North Carolina
United States Ohio State University Columbus Ohio
United States Duke University Medical Center Durham North Carolina
United States Hackensack University Medical Center Hackensack New Jersey
United States Indiana Heart Hospital Indianapolis Indiana
United States Methodist Hospital of Indiana Indianapolis Indiana
United States Dartmouth Hitchcock Medical Center Lebanon New Hampshire
United States The Mount Sinai Hospital New York New York
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States Mayo Clinic Rochester Minnesota
United States Barnes-Jewish Hospital Saint Louis Missouri
United States University of South Florida Tampa Florida

Sponsors (1)

Lead Sponsor Collaborator
Cook Group Incorporated

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Recruiting NCT04149600 - Identification of Genetic Causes of Calcific Aortic Valve Disease
Enrolling by invitation NCT04035356 - HAART Annuloplasty Device Valve Repair Registry
Recruiting NCT02729064 - Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose Phase 1
Completed NCT02467062 - Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease. N/A
Completed NCT02283307 - Dual Energy CT Urography With Reduced Iodinated Contrast N/A
Completed NCT01678261 - X-chromosome Inactivation, Epigenetics and the Transcriptome N/A
Terminated NCT01055275 - Cook Iliac Branch Graft Post-market Registry N/A
Completed NCT00615888 - Fast Track Management in Elective Open Infrarenal Aortic Aneurysm Repair N/A
Completed NCT03510793 - Microcirculation and Anesthesia in Vascular Surgery
Completed NCT03207568 - RE-GENERATION: The Safety and Performance of the Relay Pro and Relay NBS Pro Stent-graft Devices in the European Union (EU) N/A
Recruiting NCT05073991 - Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
Not yet recruiting NCT01918969 - Reference Values of Circulating Endothelial Progenitor Cells N/A
Not yet recruiting NCT01918982 - Circulating Endothelial Progenitor Cells and Aortic Aneurysm N/A
Completed NCT02000544 - Clinical Evaluation of a Modular Extracorporeal Circulation Circuit N/A
Completed NCT01256372 - An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery Phase 2
Recruiting NCT00661518 - PET/CT Imaging of Aneurysm Wall Inflammation N/A
Completed NCT00094575 - Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA) Phase 4
Recruiting NCT04471909 - NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness N/A
Recruiting NCT05603520 - Phenotyping Heterogeneity and Regionality of the Aorta
Completed NCT03727542 - Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels N/A